what this node claims
AlphaFold metrics / NTRK1
Model-quality receipt for the fold. It is not biological validation.
vertical proof spine
evidence / risk instrument
53%
low debt pressure
21%
78%structureusable
pLDDT 78.23
78%evidenceusable
grade B
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine
proof completeness
33% missing target, candidate, finding, export- 01 target
- 02 fold
- 03 alphafold metric
- 04 candidate
- 05 finding
- 06 export
Metrics and receipt inputs
- confidence band
- confident
- confidence pct
- 78.23
- coverage context
- missing or not linked
- interpretation
- usable fold context with explicit model-confidence limits
- pae context
- missing or not linked
- plddt avg
- 78.23
- sequence length
- 0
AlphaFold metrics visual
Confident backbone model
796 residues / min 23.58 / max 98.62 / source alphafold db
Very high
37.6%
299 residues / >=90
Confident
38.1%
303 residues / 70-89
Low
9.4%
75 residues / 50-69
Very low
14.9%
119 residues / <50
usable fold context with explicit model-confidence limits
Near-complete coverage / observed 796 of 796 residues.
- residues 441-500 / mean 35.47
- residues 1-38 / mean 37.89
- residues 381-418 / mean 44.3
- residues 668-675 / mean 54.61
proof debt register
21%
Visible limits, not hidden cleanup.
Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.